NO20006382L - Fremgangsmåte for behandling av organofosfatforgiftning - Google Patents
Fremgangsmåte for behandling av organofosfatforgiftningInfo
- Publication number
- NO20006382L NO20006382L NO20006382A NO20006382A NO20006382L NO 20006382 L NO20006382 L NO 20006382L NO 20006382 A NO20006382 A NO 20006382A NO 20006382 A NO20006382 A NO 20006382A NO 20006382 L NO20006382 L NO 20006382L
- Authority
- NO
- Norway
- Prior art keywords
- organophosphate poisoning
- treating organophosphate
- treating
- poisoning
- mammal
- Prior art date
Links
- 208000007964 Organophosphate Poisoning Diseases 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003379 purinergic P1 receptor agonist Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/097,505 US20020058669A1 (en) | 1998-06-15 | 1998-06-15 | Process for the treatment of organophosphate poisoning |
| PCT/NL1998/000343 WO1999065501A1 (fr) | 1998-06-15 | 1998-06-15 | Procede pour traiter un empoisonnement aux composes organophosphores |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006382D0 NO20006382D0 (no) | 2000-12-14 |
| NO20006382L true NO20006382L (no) | 2001-01-24 |
Family
ID=26647321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006382A NO20006382L (no) | 1998-06-15 | 2000-12-14 | Fremgangsmåte for behandling av organofosfatforgiftning |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20020058669A1 (fr) |
| EP (1) | EP1087776A1 (fr) |
| CN (1) | CN1301167A (fr) |
| NO (1) | NO20006382L (fr) |
| WO (1) | WO1999065501A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1636229A4 (fr) * | 2003-06-06 | 2008-07-30 | Endacea Inc | Antagonistes du recepteur d'adenosine a1 |
| AU2007338878A1 (en) * | 2006-11-13 | 2008-07-03 | Ateris Technologies, Llc | Pesticide biomarker |
| US10478438B2 (en) | 2008-10-16 | 2019-11-19 | David Reed Helton | Treatment of organophosphate exposure with ocinaplon |
| CN116509817A (zh) * | 2023-04-13 | 2023-08-01 | 中国人民解放军军事科学院军事医学研究院 | 一种腺苷受体伴随开放血脑屏障的纳米药物、其制备方法及对抗神经毒剂中毒的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5356690A (en) * | 1976-09-30 | 1978-05-23 | Rikagaku Kenkyusho | Purin compund sugar derivatives and their preparation |
| AU7331094A (en) * | 1993-07-13 | 1995-02-13 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | A3 adenosine receptor agonists |
-
1998
- 1998-06-15 CN CN98814115A patent/CN1301167A/zh active Pending
- 1998-06-15 WO PCT/NL1998/000343 patent/WO1999065501A1/fr not_active Ceased
- 1998-06-15 EP EP98931122A patent/EP1087776A1/fr not_active Withdrawn
- 1998-06-15 US US09/097,505 patent/US20020058669A1/en not_active Abandoned
-
2000
- 2000-12-14 NO NO20006382A patent/NO20006382L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999065501A1 (fr) | 1999-12-23 |
| NO20006382D0 (no) | 2000-12-14 |
| EP1087776A1 (fr) | 2001-04-04 |
| US20020058669A1 (en) | 2002-05-16 |
| CN1301167A (zh) | 2001-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69700748D1 (de) | Egm aufzeichnungssystem für implantierbare medizinische vorrichtung | |
| DE69705312D1 (de) | N6-heterocyclisch-substituierte adenosin-derivate | |
| DK0733628T3 (da) | 5-substituerede 3-(1,2,3,6-tetrahydropyridin-4-yl)- og 3-(piperidin-4-yl)-1H-indoler: 5HT1F-agonister | |
| DE69637843D1 (de) | Verbundfolie-feuchtigkeitssperre für zellentester | |
| NO974213L (no) | Små-molekylære inhibitorer for rotamase-enzym-aktivitet | |
| WO2001077951A8 (fr) | Systeme et procedes pour administrer un plan de retraite de groupe | |
| ATE185341T1 (de) | 4,9-ethano-benzo(f)isoindolderivate als farnesyl transferase inhibitoren | |
| DE69636998D1 (de) | Bidirekektionssperrender akkumulations-grabenleitungs-mosfet | |
| BR9907256A (pt) | Inibidores beta-cetoamida de proteassoma 20s | |
| BR9607193B1 (pt) | teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos. | |
| NO970519D0 (no) | Behandling av type II diabetes mellitus med amylinagonister | |
| DE69627179D1 (de) | Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren | |
| NO883505D0 (no) | Fremgangsmaate for analyse av fluidums-innstroemning i oljebroenner. | |
| NO990449D0 (no) | FremgangsmÕte for hydrogenbehandling | |
| NO965546D0 (no) | Fremgangsmåte for å sikre samvirke mellom objekter i et objektorientert program | |
| NO20006382L (no) | Fremgangsmåte for behandling av organofosfatforgiftning | |
| TR199900762T2 (xx) | Stresle aktifle�tirilen protein kinazlar�n�n engellenme y�ntemi. | |
| TR199800478T1 (xx) | Diarilalkenilamin t�revleri | |
| SE9501881D0 (sv) | New pharmacological use of AII-receptor antagonists | |
| NO175402C (no) | Fremgangsmåte for å forhindre mikrobiologiske avsetninger i papirfremstillingsutstyr | |
| TR199900509T2 (xx) | Omeprazol haz�rlanmas� i�in y�ntem. | |
| DE69620944D1 (de) | Halbleiter-Prüfmethode | |
| FI960534L (fi) | Menetelmä analyyttien ei-kilpailevaa määritystä varten | |
| KR960702945A (ko) | Amg eprom의 액세스 트랜지스터 영역에서 비트라인-비트라인 누설 전류를 방지하기 위한 방법(a method for preventing bit line-to-bit line leakage in the access transistor region of an amg eprom) | |
| NO991096L (no) | Nye fremgangsmÕter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |